Schedule of Accounts Payable (Details) - USD ($) |
Jun. 30, 2024 |
Dec. 31, 2023 |
||
|---|---|---|---|---|
| Payables and Accruals [Abstract] | ||||
| Accounts payable to Cytovance, a related party | [1] | $ 842,000 | $ 3,515,000 | |
| Other accounts payable | 875,000 | 813,000 | ||
| Total accounts payable | $ 1,717,000 | $ 4,328,000 | ||
| ||||
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|